Adagio Medical Holdings Statistics
Total Valuation
ADGM has a market cap or net worth of $2.89 million. The enterprise value is $21.15 million.
| Market Cap | 2.89M |
| Enterprise Value | 21.15M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026, after market close.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADGM has 22.21 million shares outstanding. The number of shares has increased by 42.93% in one year.
| Current Share Class | 22.21M |
| Shares Outstanding | 22.21M |
| Shares Change (YoY) | +42.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.17% |
| Owned by Institutions (%) | 7.84% |
| Float | 8.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 5.55 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.41
| Current Ratio | 1.41 |
| Quick Ratio | 1.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.38 |
Financial Efficiency
Return on equity (ROE) is -657.76% and return on invested capital (ROIC) is -47.62%.
| Return on Equity (ROE) | -657.76% |
| Return on Assets (ROA) | -35.52% |
| Return on Invested Capital (ROIC) | -47.62% |
| Return on Capital Employed (ROCE) | -75.31% |
| Weighted Average Cost of Capital (WACC) | 8.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$661,854 |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | 0.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.22% in the last 52 weeks. The beta is 0.01, so ADGM's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -94.22% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 0.82 |
| Relative Strength Index (RSI) | 21.72 |
| Average Volume (20 Days) | 2,554,283 |
Short Selling Information
The latest short interest is 412,796, so 1.86% of the outstanding shares have been sold short.
| Short Interest | 412,796 |
| Short Previous Month | 259,188 |
| Short % of Shares Out | 1.86% |
| Short % of Float | 4.88% |
| Short Ratio (days to cover) | 1.56 |
Income Statement
| Revenue | n/a |
| Gross Profit | -89,000 |
| Operating Income | -19.82M |
| Pretax Income | -27.14M |
| Net Income | -27.14M |
| EBITDA | -18.98M |
| EBIT | -19.82M |
| Earnings Per Share (EPS) | -$1.36 |
Balance Sheet
The company has $7.74 million in cash and $26.00 million in debt, with a net cash position of -$18.26 million or -$0.82 per share.
| Cash & Cash Equivalents | 7.74M |
| Total Debt | 26.00M |
| Net Cash | -18.26M |
| Net Cash Per Share | -$0.82 |
| Equity (Book Value) | -415,000 |
| Book Value Per Share | -0.02 |
| Working Capital | 3.13M |
Cash Flow
In the last 12 months, operating cash flow was -$16.53 million and capital expenditures -$37,000, giving a free cash flow of -$16.57 million.
| Operating Cash Flow | -16.53M |
| Capital Expenditures | -37,000 |
| Depreciation & Amortization | 839,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -16.57M |
| FCF Per Share | -$0.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADGM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -42.93% |
| Shareholder Yield | n/a |
| Earnings Yield | -939.82% |
| FCF Yield | -573.88% |
Analyst Forecast
The average price target for ADGM is $3.33, which is 2,461.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.33 |
| Price Target Difference | 2,461.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |